{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:22:51Z","timestamp":1785403371706,"version":"3.56.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009992","name":"Seattle Children's Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009992","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009993","name":"Center for Clinical and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009993","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jpeds.2015.07.070","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T09:15:17Z","timestamp":1441098917000},"page":"88-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Intravenous Hydralazine in Hospitalized Children and Adolescents with Hypertension"],"prefix":"10.1016","volume":"168","author":[{"given":"Joseph T.","family":"Flynn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3385-0541","authenticated-orcid":false,"given":"Miranda C.","family":"Bradford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 Suppl 4th Report","key":"10.1016\/j.jpeds.2015.07.070_bib1","first-page":"555","article-title":"The 4th report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.07.070_bib2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/01.mop.0000150769.38484.b3","article-title":"Advances in the pathogenesis and management of hypertensive crisis","volume":"17","author":"Patel","year":"2005","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jpeds.2015.07.070_bib3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00467-008-1000-1","article-title":"Severe hypertension in children and adolescents: pathophysiology and treatment","volume":"24","author":"Flynn","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpeds.2015.07.070_bib4","series-title":"Goodman and Gilman\u2019s the pharmacological basis of therapeutics","first-page":"845","article-title":"Therapy of hypertension","author":"Hoffman","year":"2006"},{"key":"10.1016\/j.jpeds.2015.07.070_bib5","series-title":"Prescribing information, hydralazine hydrochloride injection","year":"2003"},{"key":"10.1016\/j.jpeds.2015.07.070_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.12.1.29","article-title":"Effects of hydrazinophthalazine (Apresoline) on blood pressure and renal function in children with acute nephritis","volume":"12","author":"McCrory","year":"1953","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.07.070_bib7","first-page":"451","article-title":"Hydralazine in nephritic and normal children with renal hemodynamic studies","volume":"89","author":"Etteldorf","year":"1955","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jpeds.2015.07.070_bib8","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0022-3476(69)80054-5","article-title":"Hypertension in children and adolescents. II. Drug therapy","volume":"74","author":"Loggie","year":"1969","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2015.07.070_bib9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/adc.67.9.1089","article-title":"Management of hypertensive emergencies","volume":"67","author":"Deal","year":"1992","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2015.07.070_bib10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11906-014-0456-6","article-title":"Pediatric hypertensive emergencies","volume":"16","author":"Baracco","year":"2014","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jpeds.2015.07.070_bib11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00467-014-2772-0","article-title":"The efficacy and safety of intravenous hydralazine for the treatment of hypertension in the hospitalized child","volume":"29","author":"Ostrye","year":"2014","journal-title":"Pediatr Nephrol"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347615008562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347615008562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:58:38Z","timestamp":1758358718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347615008562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":11,"alternative-id":["S0022347615008562"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2015.07.070","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Hydralazine in Hospitalized Children and Adolescents with Hypertension","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2015.07.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2015.09.071","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}